8 posts tagged IP strategy from Commercializing Science.
Reach-through royalty provisions look like smart IP protection but routinely kill university-industry deals. Here's what to do instead.
A. KovacsMost NDAs in university-industry research partnerships are written to protect everyone and end up protecting no one. Here's why, and what to do instead.
A. KovacsField-of-use restrictions in university license agreements promise focused commercialization but routinely strangle deal value and block better applications from reaching market.
A. KovacsVague IP assignment language in sponsored research agreements creates ownership disputes that kill commercialization deals years after the science is done.
A. KovacsExclusive licenses feel like wins for everyone at signing. Here's why they quietly kill commercialization, and what to structure instead.
A. KovacsInvention disclosure forms are often the first step in tech transfer, and one of the most damaging. Here's what needs to change.
A. KovacsSponsored research agreements shape IP ownership, licensing rights, and spinout potential before a patent is ever filed. Here's what most researchers miss.
A. Kovacs